What are the medications used to treat hyperthyroidism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications for Hyperthyroidism

The primary medications used to treat hyperthyroidism are thionamide-derived antithyroid drugs (methimazole/carbimazole and propylthiouracil) and beta blockers, with methimazole being the preferred first-line agent for most patients except during the first trimester of pregnancy. 1, 2, 3

First-Line Antithyroid Medications

Thionamide-Derived Drugs

  1. Methimazole (MMI)/Carbimazole (CBZ)

    • Mechanism: Inhibits thyroid hormone synthesis 2
    • Dosing:
      • Initial dose: 20-40 mg daily (based on severity)
      • Maintenance dose: 5-10 mg daily 4
    • Advantages:
      • Once-daily dosing
      • Lower risk of severe hepatotoxicity than PTU 1
  2. Propylthiouracil (PTU)

    • Mechanism: Inhibits thyroid hormone synthesis and peripheral conversion of T4 to T3 3
    • Dosing: 150-200 mg daily in divided doses 4
    • Special indications:
      • First trimester of pregnancy (should switch to MMI after first trimester) 3
      • Thyroid storm (due to additional inhibition of T4 to T3 conversion) 3, 5

Symptomatic Management

Beta Blockers

  • Propranolol: 60-80 mg orally every 4-6 hours or 1-2 mg IV slowly 1
  • Esmolol: Alternative for hemodynamically unstable patients 1
  • Indications:
    • Control of adrenergic symptoms (tachycardia, tremor, anxiety)
    • First-line treatment for thyrotoxic crisis 1
    • Used alongside antithyroid drugs until euthyroid state is achieved 6, 1

Non-Dihydropyridine Calcium Channel Antagonists

  • Alternative when beta blockers are contraindicated 6
  • Helps control ventricular rate, especially in patients with atrial fibrillation due to hyperthyroidism 6

Treatment Duration and Monitoring

  • Standard treatment course: 12-18 months of antithyroid drugs 4, 7
  • Long-term treatment (5-10 years) may be considered in select cases with fewer recurrences (15%) compared to short-term treatment 7
  • Monitor thyroid function tests every 4-6 weeks initially, then every 6-12 months when stable 1
  • Watch for side effects:
    • Agranulocytosis (rare but serious)
    • Hepatotoxicity (more common with PTU)
    • Skin rash 3

Treatment Selection Based on Etiology

  1. Graves' Disease (accounts for ~70% of hyperthyroidism cases):

    • First-line: Antithyroid drugs (methimazole preferred) 7
    • Alternatives: Radioactive iodine or surgery
  2. Toxic Nodular Goiter (accounts for ~16% of cases):

    • Antithyroid drugs less effective long-term due to high relapse rates 8
    • Definitive treatment with radioactive iodine or surgery usually preferred 7
  3. Thyroiditis-Induced Thyrotoxicosis:

    • Beta blockers for symptomatic control
    • Antithyroid drugs not effective (condition is due to release, not production) 7
    • Self-limiting condition in most cases 9

Special Considerations

  • Pregnancy: PTU preferred in first trimester, then switch to methimazole 3
  • Breastfeeding: Methimazole/carbimazole can be used 4
  • Thyroid Storm: Requires aggressive treatment with PTU, beta blockers, corticosteroids, and supportive care 1, 5
  • Elderly Patients: May need lower doses and more careful monitoring for cardiovascular complications 1

Common Pitfalls

  • Failure to recognize that antithyroid drugs don't inactivate existing thyroid hormones, only prevent new synthesis 2, 3
  • Overtreatment with antithyroid drugs leading to hypothyroidism
  • Not monitoring for serious side effects like agranulocytosis or hepatotoxicity 3
  • Using antithyroid drugs in thyroiditis where they are ineffective 7
  • Not providing beta blockers for symptomatic relief during initial treatment phase 6, 1

References

Guideline

Thyroid Disease Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of Graves' hyperthyroidism with thionamides-derived drugs: review.

Medicinal chemistry (Shariqah (United Arab Emirates)), 2010

Research

Hyperthyroidism.

Gland surgery, 2020

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hyperthyroidism.

Lancet (London, England), 2016

Research

Hyperthyroidism: A Review.

JAMA, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.